TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33704459

Group type: EXPERIMENTAL
Intervention: 600 mg quinine hydrochloride (QHCl) administered intragastrically (IG)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 600 mg quinine hydrochloride (QHCl) administered intraduodenally (ID)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no quinine) administered intragastrically (IG)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no quinine) administered intraduodenally (ID)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 600 mg quinine hydrochloride (QHCl)
Number of subjects: 14
Study: 32303242

Group type: EXPERIMENTAL
Intervention: Modified Stoppa approach
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ilioinguinal approach
Number of subjects: 38
Study: 35227982

Group type: EXPERIMENTAL
Intervention: Exposure to pure tone sequences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to complex tone sequences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to complex tones with odd harmonics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to complex tones with even harmonics
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-exposure control group
Number of subjects: 0
Study: 32357579

Group type: EXPERIMENTAL
Intervention: Vitamin D tablets (1600 IU/day)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Vitamin D oil drops (1500 IU/day)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Vitamin D oil drops (1500 IU/day) in patients without immunoglobulin replacement
Number of subjects: 206

Group type: COMPARATOR
Intervention: Vitamin D tablets (1600 IU/day) in patients without immunoglobulin replacement
Number of subjects: 206
Study: 33339480

Group type: EXPERIMENTAL
Intervention: Algorithm-based RCA protocol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Trial-and-error RCA protocol
Number of subjects: 18
Study: 32787497

Group type: EXPERIMENTAL
Intervention: 24-epibrassinolide (EBR) at 5 nM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 24-epibrassinolide (EBR) at 10 nM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (0 nM EBR) under waterlogging
Number of subjects: 0
Study: 35568284

Group type: EXPERIMENTAL
Intervention: Individualised technique of IM‐MS RT
Number of subjects: 4004

Group type: EXPERIMENTAL
Intervention: Standard-modified technique of IM‐MS RT
Number of subjects: 4004

Group type: EXPERIMENTAL
Intervention: Standard technique of IM‐MS RT
Number of subjects: 4004

Group type: COMPARATOR
Intervention: No IM‐MS RT
Number of subjects: 4004
Study: 35103609

Group type: EXPERIMENTAL
Intervention: Smartphone app and smart band (Mi Band 2, Xiaomi) with brief counseling
Number of subjects: 650

Group type: COMPARATOR
Intervention: Brief counseling only
Number of subjects: 650
Study: 35488356

Group type: EXPERIMENTAL
Intervention: Early prone position (PP) + noninvasive ventilation (NIV)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional (supine) NIV
Number of subjects: 81
Study: 32023661

Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection (FMD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Full-mouth ultrasonic debridement (FMUD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Quadrant-wise scaling and root planning (Q-SRP)
Number of subjects: 60
Study: 36001541

Group type: EXPERIMENTAL
Intervention: Social media usage restricted to a maximum of 10 minutes per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32383548

Group type: EXPERIMENTAL
Intervention: 5% sodium ascorbyl phosphate (SAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5% ascorbic acid (AA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 33634677

Group type: EXPERIMENTAL
Intervention: 2 daily sessions per muscle group (2S)
Number of subjects: 23

Group type: COMPARATOR
Intervention: 1 daily session per muscle group (1S)
Number of subjects: 23
Study: 33225618

Group type: EXPERIMENTAL
Intervention: First semester %BMIp95 change
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Second semester %BMIp95 change
Number of subjects: 174
Study: 32901113

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes mellitus (T2DM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32805434

Group type: EXPERIMENTAL
Intervention: LIFT mobile app‐based mindfulness intervention
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Therapist introduction
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Therapist response to symptoms
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: High dose of intervention
Number of subjects: 152

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 152
Study: 35339908

Group type: EXPERIMENTAL
Intervention: Family-oriented dignity therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Attention (control group)
Number of subjects: 120
Study: 34371972

Group type: COMPARATOR
Intervention: DHA-rich n-3 PUFA supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of DHA-rich n-3 PUFA supplementation and RT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 0
Study: 35433468

Group type: COMPARATOR
Intervention: dSAPB combined with 30 ml of 0.375% ropivacaine (Group R)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: dSAPB combined with 30 ml of 0.375% ropivacaine plus dexmedetomidine (1 μg/kg) (Group RD)
Number of subjects: 80
Study: 32070136

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Antihistamine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34094998

Group type: EXPERIMENTAL
Intervention: AIH group
Number of subjects: 204

Group type: COMPARATOR
Intervention: HC group
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Discovery cohort (46 AIH and 92 HCs)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Validation cohort (22 AIH and 44 HCs)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Cross-regional validation cohort (12 AIH)
Number of subjects: 204
Study: 33083468

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 36231235

Group type: EXPERIMENTAL
Intervention: True SAS intervention (daily self-administered acupressure on specific acupoints for seven weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo SAS (light acupressure on non-acupoints with the same frequency and duration as the true SAS)
Number of subjects: 0
Study: 34435347

Group type: EXPERIMENTAL
Intervention: Structured contraceptive counseling
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Effectiveness chart
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Box of contraceptive models
Number of subjects: 658

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 658
Study: 32143699

Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) training
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Previous contact with someone with a mental health problem
Number of subjects: 140
Study: 34437960

Group type: EXPERIMENTAL
Intervention: PTFE bypass
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Vein bypass (VBP)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Nitinol stents
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 172
Study: 36495242

Group type: EXPERIMENTAL
Intervention: MWA + PVP
Number of subjects: 67

Group type: COMPARATOR
Intervention: PVP
Number of subjects: 67
Study: 32886200

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block (ESPB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no ESPB)
Number of subjects: 80
Study: 32794309

Group type: EXPERIMENTAL
Intervention: Non-transvenous ICD systems
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transvenous ICD systems
Number of subjects: 0
Study: 35894920

Group type: EXPERIMENTAL
Intervention: Dynamic moment of inertia bat
Number of subjects: 39

Group type: COMPARATOR
Intervention: Weighted bat
Number of subjects: 39
Study: 32867560

Group type: EXPERIMENTAL
Intervention: Asthma question prompt list with video intervention
Number of subjects: 359

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 359
Study: 32861500

Group type: EXPERIMENTAL
Intervention: Continuous infusion of epinephrine 0.1 μg kg-1 min-1
Number of subjects: 82

Group type: COMPARATOR
Intervention: Continuous infusion of phenylephrine 1 μg kg-1 min-1
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Continuous infusion of epinephrine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Continuous infusion of phenylephrine
Number of subjects: 82
Study: 36334724

Group type: EXPERIMENTAL
Intervention: Vaginal seeding (n=60; infants swabbed immediately after birth using gauze preincubated in maternal vagina)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n=60; routine standard care)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vaginal seeding
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 33875418

Group type: EXPERIMENTAL
Intervention: Targeted postal intervention (posted letter and leaflet)
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1513
Study: 32208006

Group type: EXPERIMENTAL
Intervention: Patient summary format (n=203)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Traditional unstructured format (n=203)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Traditional unstructured + patient summary format (n=203)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Radiology colloquialisms (n=203)
Number of subjects: 203
Study: 87088248

Group type: EXPERIMENTAL
Intervention: Alcohol-Focused Spouse Involvement plus Behavioral Marital Therapy (ABMT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Alcohol-Focused Spouse Involvement (AFSI)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Minimal Spouse Involvement (MSI)
Number of subjects: 53
Study: 35996106

Group type: EXPERIMENTAL
Intervention: Robot-assisted virtual reality mirror therapy (RAVRMT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Virtual reality mirror therapy (VRMT)
Number of subjects: 32
Study: 34808745

Group type: EXPERIMENTAL
Intervention: DRG‐PRF treatment assisted by 3D‐printed navigation template
Number of subjects: 63

Group type: COMPARATOR
Intervention: DRG‐PRF treatment guided by conventional CT
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 36198457

Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (TAVNS)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 88
Study: 33669711

Group type: EXPERIMENTAL
Intervention: Burden of prevention and adjustment effort to the pandemic felt by female doctors and GPs working in associated offices.
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Case definition quality, support received, professional life changes, and stress symptoms.
Number of subjects: 677

Group type: EXPERIMENTAL
Intervention: Adjustment measurement questionnaire.
Number of subjects: 677
Study: 36250614

Group type: EXPERIMENTAL
Intervention: Behaviour Change Wheel (BCW) intervention including pre-discharge evaluation sessions, personalised resource folder, tailored behavioural and text message support post-discharge, and a peer interaction group delivered by a trained mental health worker.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behaviour Change Techniques (BCTs) such as goal setting, problem solving, feedback, social support, and information on health consequences.
Number of subjects: 0
Study: 32662168

Group type: EXPERIMENTAL
Intervention: Psychoeducation program (90-min sessions once a week for 9 weeks)
Number of subjects: 80
Study: 35587714

Group type: EXPERIMENTAL
Intervention: Spironolactone treatment in Phenotype 1
Number of subjects: 1540

Group type: COMPARATOR
Intervention: Phenotype 2
Number of subjects: 1540

Group type: COMPARATOR
Intervention: Phenotype 3
Number of subjects: 1540
Study: 35120498

Group type: EXPERIMENTAL
Intervention: Team-based learning
Number of subjects: 107

Group type: COMPARATOR
Intervention: Group discussions
Number of subjects: 107
Study: 33057792

Group type: EXPERIMENTAL
Intervention: Severe punches with the fist
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Karate chop (small finger edge of the hand)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Open hand strikes
Number of subjects: 50
Study: 35755939

Group type: EXPERIMENTAL
Intervention: 1 egg/day for 6 months
Number of subjects: 585
Study: 34371058

Group type: EXPERIMENTAL
Intervention: Jedi Grip technique
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 92
Study: 34540184

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine with 1 ?g/kg DEX (PRD group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine (PR group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Routine general anesthesia (G group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 60
Study: 35964309

Group type: EXPERIMENTAL
Intervention: 90-minute workshop for universal suicide prevention (intervention group)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 305
Study: 33852780

Group type: EXPERIMENTAL
Intervention: Psilocybin (25 mg, two doses 3 weeks apart plus 6 weeks of daily placebo)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Escitalopram (1 mg, two doses 3 weeks apart plus 6 weeks of daily oral escitalopram)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 59

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 59
Study: 35312525

Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone (SFC)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Tiotropium (TIO)
Number of subjects: 134

Group type: COMPARATOR
Intervention: High-FENO/SFC
Number of subjects: 134

Group type: COMPARATOR
Intervention: Low-FENO/SFC
Number of subjects: 134

Group type: COMPARATOR
Intervention: Low-FENO/TIO
Number of subjects: 134

Group type: COMPARATOR
Intervention: High-FENO/TIO
Number of subjects: 134
Study: 35074611

Group type: EXPERIMENTAL
Intervention: Renin-angiotensin-aldosterone system (RAAS) inhibition (losartan)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sympathoinhibition (moxonidine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33050917

Group type: EXPERIMENTAL
Intervention: Intervention group (providers see PRO results on the same screen as the CTCAE rating)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no access to PRO data during the CTCAE rating)
Number of subjects: 0
Study: 32646295

Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Journaling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gratitude
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outside
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 33737313

Group type: EXPERIMENTAL
Intervention: Early ACL reconstruction (index)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Rehabilitation plus optional reconstruction (comparator)
Number of subjects: 167
Study: 33812837

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 94
Study: 37697324

Group type: EXPERIMENTAL
Intervention: 3D‐DST (clinical decision assessment system)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual paper version (control group)
Number of subjects: 0
Study: 33485646

Group type: EXPERIMENTAL
Intervention: 3.75 µg H7N9 IIV adjuvanted with MF59
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: 7.5 µg H7N9 IIV adjuvanted with MF59
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: 15 µg H7N9 IIV adjuvanted with MF59
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: 3-dose series on days 1, 28 and 168
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: 3-dose series on days 1, 57 and 168
Number of subjects: 479

Group type: COMPARATOR
Intervention: Recent prior receipt of seasonal influenza vaccine
Number of subjects: 479
Study: 32381048

Group type: EXPERIMENTAL
Intervention: Point-of-care bedside ultrasound (PoCUS)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Point-of-care bedside ultrasound (PoCUS) by expert
Number of subjects: 242

Group type: COMPARATOR
Intervention: Radiographic imaging
Number of subjects: 242
Study: 35952426

Group type: EXPERIMENTAL
Intervention: Test agent nasal spray, administered 3 times daily over a 45 day course
Number of subjects: 556

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556
Study: 35969169

Group type: EXPERIMENTAL
Intervention: Hypnotically delivered pain science education
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pain science education with progressive muscle relaxation
Number of subjects: 20
Study: 35936366

Group type: EXPERIMENTAL
Intervention: Carvedilol combined with conventional antihypertensive therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional antihypertensive therapy
Number of subjects: 80
Study: 33492568

Group type: EXPERIMENTAL
Intervention: Abemaciclib 150 mg every 12 h on a 28-day cycle
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Abemaciclib 200 mg every 12 h on a 28-day cycle
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Abemaciclib (both dosages)
Number of subjects: 26
Study: 32115419

Group type: EXPERIMENTAL
Intervention: Endovascular embolization only
Number of subjects: 26
Study: 35440798

Group type: EXPERIMENTAL
Intervention: Online positive parenting programme (PPP)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Active control group (general education)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 103
Study: 33586058

Group type: EXPERIMENTAL
Intervention: Patient-managed titration of insulin glargine 300 U/mL (Gla-300)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physician-managed titration of insulin glargine 300 U/mL (Gla-300)
Number of subjects: 0
Study: 36336245

Group type: EXPERIMENTAL
Intervention: Ivermectin Mass Drug Administration (MDA)
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1052
Study: 34011198

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study: 32057125

Group type: EXPERIMENTAL
Intervention: Sodium oxybate treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal sleep
Number of subjects: 0
Study: 34114623

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg bid
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg bid
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ticagrelor 90 mg dosing
Number of subjects: 92

Group type: COMPARATOR
Intervention: VerifyNow and LTA assessments
Number of subjects: 92

Group type: COMPARATOR
Intervention: PK assessments in CKD patients
Number of subjects: 92
Study: 34641897

Group type: EXPERIMENTAL
Intervention: GnRH antagonist pretreatment for 3 days before stimulation
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional GnRH antagonist protocol (without pretreatment)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: GnRH antagonist pretreatment
Number of subjects: 136
Study: 34448875

Group type: EXPERIMENTAL
Intervention: 700 mg phosphorus (NaH2PO4)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 33622116

Group type: EXPERIMENTAL
Intervention: Ischemic Preconditioning (IPC) - 4 × 5 minutes of individualized total occlusion pressure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham protocol - 4 × 5 minutes using 20 mm Hg
Number of subjects: 30
Study: 34152936

Group type: EXPERIMENTAL
Intervention: Indoor daylight photodynamic therapy (idl-PDT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional photodynamic therapy (cPDT)
Number of subjects: 43
Study: 34758798

Group type: EXPERIMENTAL
Intervention: Older prisoner Health and Social Care Assessment and Plan (OHSCAP)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Comparison between OHSCAP and TAU
Number of subjects: 202
Study: 33180640

Group type: EXPERIMENTAL
Intervention: SQUAT (15 chair stands with calf raise)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: WALK (2 min at 3.1 mph)
Number of subjects: 14

Group type: COMPARATOR
Intervention: SIT (uninterrupted sitting)
Number of subjects: 14
Study: 32602079

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SLC)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Multiport laparoscopic cholecystectomy (MLC)
Number of subjects: 193
Study: 35524417

Group type: EXPERIMENTAL
Intervention: Extendable‐retractable helix leads (EHL)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Fixed‐helix leads (FHL)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: EHL
Number of subjects: 280

Group type: COMPARATOR
Intervention: FHL
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: EHL and FHL
Number of subjects: 280
Study: 33610215

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (EBRT) (20 Gy in five fractions or 30 Gy in ten fractions) plus usual care
Number of subjects: 199

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (EBRT)
Number of subjects: 199
Study: 35195549

Group type: EXPERIMENTAL
Intervention: Atomoxetine (Strattera)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106
Study: 32157772

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sitagliptin (100 mg)
Number of subjects: 76